Description
Cyramza Ramucirumab 500mg Injection: Uses, Side Effects, and Precautions
Cyramza (Ramucirumab) 500mg Injection is a monoclonal antibody used to treat metastatic non-small cell lung cancer (NSCLC), colorectal cancer, and stomach cancer. It blocks the vascular endothelial growth factor (VEGF) receptor, preventing the formation of new blood vessels that supply tumors with nutrients and oxygen.
Dosage and Administration
A healthcare provider administers Cyramza as an intravenous (IV) infusion. The dosage and frequency depend on the type of cancer, the patient’s condition, and treatment response. Following the prescribed schedule is crucial for optimal results.
Common Side Effects
- Fatigue
- High blood pressure
- Diarrhea
- Decreased appetite
- Bleeding or bruising
- Pain or redness at the injection site
Serious Side Effects
- Severe bleeding, including gastrointestinal bleeding, nosebleeds, or coughing up blood
- Heart problems, such as chest pain or irregular heartbeat
- Blood clots, leading to symptoms like swelling, pain, or shortness of breath
- Liver issues, including jaundice (yellowing of the skin or eyes)
- Gastrointestinal perforation, causing pain, nausea, or vomiting
Seek immediate medical attention if any of these serious side effects occur.
Precautions and Warnings
- Bleeding disorders or heart conditions: Inform your doctor before starting treatment.
- Liver function monitoring is necessary due to potential liver damage.
- Pregnancy and breastfeeding: Avoid use, as it may harm the baby.
- Medication interactions: Inform your doctor about all medications to prevent potential interactions.
Disclaimer:
Products information mentioned on this site is for informative purposes only. The product image belongs to the respective company. Genetec Lifesciences is a wholesaler and distributor, not a manufacturer. We source our medicines directly from the company or authorized vendors of the company.